高级检索
当前位置: 首页 > 详情页

Dual stimuli-responsive nanocarriers based on polyethylene glycol-mediated schiff base interactions for overcoming tumour chemoresistance.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Dermatology, West China Hospital, Sichuan University, Chengdu 610041, PR China [2]National Engineering Research Center for Biomaterials and College of Biomedical Engineering, Sichuan University, Chengdu 610064, PR China [3]Public Health Clinical Center of Chengdu, Chengdu 610041, PR China [4]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network West China Hospital, Sichuan University, Chengdu 610041, PR China
出处:
ISSN:

关键词: Dual-responsive Aminal Reverse drug resistance Mannich-type condensation Enhanced anticancer efficacy

摘要:
Multifunctional and stimulus-sensitive intelligent nanodrug delivery systems (NDDSs) can significantly optimize the effectiveness of theranostic agents for cancer treatment. In this study, redox and pH dual-responsive nanocarriers (CPNPs) were prepared through molecular assembly by utilizing the Schiff base interactions of cystamine (Cys), PEG-NH2 and formaldehyde (FA) under aqueous conditions with a one-pot, one-step technique. First, the degradation products of CPNPs exhibited good biocompatibility, and the high concentration of intact CPNPs (200 µg/mL) could inhibit the growth of cells. In addition, doxorubicin (DOX) was encapsulated in CPNPs simply by changing the pH (DOX@CPNPs), and pH/GSH-responsive release behaviour was confirmed. In vitro, CPNPs significantly increased the uptake of DOX and enhanced the cytotoxicity of DOX to tumour cells. More importantly, DOX@CPNPs strongly reversed drug resistance in three different types of cancer cells, exhibiting significant anticancer effects. Collectively, this study presents the easy preparation of nanomedicines that respond to multiple stimuli, which highlights the advantages of Schiff base-based nanomedicines for cancer therapy and reversing chemoresistance.Copyright © 2022 Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 工程技术
小类 | 2 区 材料科学:生物材料 2 区 生物物理 2 区 物理化学
最新[2023]版:
大类 | 2 区 医学
小类 | 1 区 生物物理 2 区 物理化学 3 区 材料科学:生物材料
第一作者:
第一作者机构: [1]Department of Dermatology, West China Hospital, Sichuan University, Chengdu 610041, PR China [4]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network West China Hospital, Sichuan University, Chengdu 610041, PR China
通讯作者:
通讯机构: [1]Department of Dermatology, West China Hospital, Sichuan University, Chengdu 610041, PR China [4]Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network West China Hospital, Sichuan University, Chengdu 610041, PR China [*1]Department of Dermatology, West China Hospital, Sichuan University, Chengdu 610041, PR China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46425 今日访问量:0 总访问量:3323 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号